x

Search for a clinical trial

* (*) mandatory field

An Open-Label, Multicenter, Phase 1a/1b Study of Olaratumab (LY3012207) Plus Pembrolizumab (MK3475) in Patients With Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma (STS) Who Have Failed Standard Treatments- BE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Eli lilly and company world headquarters
  • Website
    • Phase : I
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • General medical oncology/Algemene Medische Oncologie
  • University Hospitals Leuven - Gasthuisberg
  • Herestraat 49
  • 3000 LEUVEN
  • BELGIUM
  • More information
  • Phone  : +32 (0)16 34 69 00
  • Fax  : +32 (0)16 34 69 01
  • Website
Last update: May 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.